Clinical experience with 6-month subcutaneous leuprolide acetate for central precocious puberty

被引：0
|
作者：
Matushek, Jori [1 ]
Boldt-Houle, Deborah M. [2 ]
Atkinson, Stuart N. [2 ]
机构：
[1] Peyton Manning Childrens Hosp St Vincent, Pediat Endocrinol & Diabet, Indianapolis, IN USA
[2] Tolmar Pharmaceut Inc, Med Affairs, Buffalo Grove, IL USA
来源：
JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES | 2023年 / 72卷
关键词：
D O I：
10.1016/j.pedn.2023.06.042
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
12
引用
收藏
页码：202 / 203
页数：2
相关论文
共 50 条
  • [41] EFFICACY OF LEUPROLIDE THERAPY IN CHILDREN WITH CENTRAL PRECOCIOUS PUBERTY
    KAPPY, MS
    STUART, T
    PERELMAN, A
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1988, 142 (10): : 1061 - 1064
  • [42] Sequential comparisons of one-month and three-month depot leuprolide regimens in central precocious puberty
    Badaru, A
    Wilson, DM
    Bachrach, LK
    Fechner, P
    Gandrud, LM
    Durham, E
    Wintergerst, K
    Chi, C
    Klein, KO
    Neely, EK
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (05): : 1862 - 1867
  • [43] Efficacy of Leuprolide Acetate 1-Month Depot for Central Precocious Puberty (CPP): Growth Outcomes During a Prospective, Longitudinal Study
    Lee, Peter A.
    Neely, E. Kirk
    Fuqua, John
    Yang, Di
    Larsen, Lois M.
    Mattia-Goldberg, Cynthia
    Chwalisz, Kristof
    INTERNATIONAL JOURNAL OF PEDIATRIC ENDOCRINOLOGY, 2011,
  • [44] PHARMACOKINETICS AND PHARMACODYNAMICS OF LEUPROLIDE ACETATE 6-MONTH DEPOT IN PATIENTS WITH PROSTATE CANCER
    Mostafa, Nael
    Chwalisz, Kristof
    Larsen, Lois
    Mattia-Goldberg, Cynthia
    Young, Jay M.
    Spitz, Aaron
    Pradhan, Rajendra
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1091 - 1091
  • [45] A 12-month clinical study of LA-2585 (45.0 MG): A new 6-month subcutaneous delivery system for Leuprolide acetate for the treatment of prostate cancer
    Crawford, ED
    Sartor, O
    Chu, F
    Perez, R
    Karlin, G
    Garrett, JS
    JOURNAL OF UROLOGY, 2006, 175 (02): : 533 - 536
  • [46] Comparable height gain with 3-month and 1-month depot leuprolide therapy in central precocious puberty
    Chiu, H. K.
    Gunther, D. F.
    Kletter, G. B.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 120 - 121
  • [47] A COMPARISON OF THE COSTS FOR TREATING CENTRAL PRECOCIOUS PUBERTY DURING THE FIRST YEAR WITH LEUPROLIDE ACETATE INJECTIBLE AND HISTRELIN ACETATE IMPLANT
    Banahan, B. F., I
    Mayo, K.
    Summers, K. H.
    VALUE IN HEALTH, 2012, 15 (04) : A175 - A176
  • [48] LOCAL REACTIONS TO DEPOT LEUPROLIDE THERAPY FOR CENTRAL PRECOCIOUS PUBERTY
    MANASCO, PK
    PESCOVITZ, OH
    BLIZZARD, RM
    JOURNAL OF PEDIATRICS, 1993, 123 (02): : 334 - 335
  • [49] Telomere length is not altered in girls with idiopathic central precocious puberty treated with a GnRH analog - leuprolide acetate
    Furtado, Cristiana Libardi Miranda
    Iannetta, Renata
    Ferriani, Rui Alberto
    Silva, Ana Carolina J. S.
    Martinelli, Carlos Eduardo
    Calado, Rodrigo Tocantins
    dos Reis, Rosana Maria
    GYNECOLOGICAL ENDOCRINOLOGY, 2020, 36 (12) : 1119 - 1123
  • [50] Impact of 6-month triptorelin formulation on predicted adult height and basal gonadotropin levels in patients with central precocious puberty
    Yoo, Eunjoo
    Kim, Sinae
    Jung, Hye Lim
    Shim, Jung Yeon
    Shim, Jae Won
    Kim, Deok Soo
    Kwak, Ji Hee
    Kim, Eun Sil
    Yang, Aram
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
12345